Latest news with #plasmacollection

Yahoo

Haemonetics Builds Momentum with New Buy Rating and Growth Promise

Haemonetics Corporation (NYSE:HAE) is one of the . The company's stocks are upgraded to Buy despite a 9% decline in revenue, reported in the Q4 earnings call. A row of automated plasma collection devices in a modern laboratory. Headquartered in Massachusetts, Haemonetics Corporation (NYSE:HAE) is engaged in the development and supply of innovative medical technologies and systems for blood and plasma collection, surgical cell salvage, and hospital transfusion services. The company has a global reach with business operations in more than 50 countries. Its integrated solutions help improve procedural efficiency and patient care within leading hospitals. On May 8, 2025, Haemonetics Corporation (NYSE:HAE) released its Q4 2025 earnings report, which highlighted a 9% decline in revenue for the quarter and a 6% decline in fiscal 2025 due to the planned CSL transition. The revenue from the Blood Center in particular went down by 22%, while it is anticipated to decline by 23 to 26% in fiscal 2026 due to portfolio streaming. Following these results, Citi maintained a Hold rating on the stock with a price target of $71 on May 22, 2025. Later, on July 9, 2025, the company upgraded the stock from Hold to Buy rating and raised the price target to $90, reflecting faith in the company's growth potential. Haemonetics (NYSE:HAE) offers strong stability with a low beta of 0.40 and promising growth potential, projecting an 11.12% EPS increase over the next five years. While we acknowledge the potential of HAE as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Metal Stocks with Insider Buying in 2025 and 10 Energy Stocks with Insider Buying in 2025 Disclosure. None. Erreur lors de la récupération des données Connectez-vous pour accéder à votre portefeuille Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données Erreur lors de la récupération des données